Email this article to a friend
Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial
Arthritis Research & Therapy 2009, 11:R170 doi:10.1186/ar2859
